Pregnancy

Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome

Results of The CAREgiver Burden in BBS (CARE-BBS) study show multifaceted burden of hyperphagiaBOSTON, July 19, 2023 (GLOBE NEWSWIRE) --…

12 months ago

Ovaterra’s Advanced Prenatal Vitamins Provide Full Daily Choline Recommendation for Breastfeeding Mothers

Research shows that taking the full daily recommended amount of choline can play a crucial role in supporting maternal health…

1 year ago

Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec

Slynd® Slynd® is now reimbursed for 100% of Quebec women to whom it is indicated.BLAINVILLE, Quebec, July 12, 2023 (GLOBE…

1 year ago

Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems

SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today…

1 year ago

University Reproductive Associates Merges With Diamond Institute to Create a Network of Fertility Clinics in Both Northern New Jersey and New York

The merger will combine URA's exclusive technology and expertise with Diamond Institute's best fertility specialists to create one of the…

1 year ago

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage

PRINCETON, NJ / ACCESSWIRE / July 11, 2023 / - In June, President Biden issued an Executive Order on Strengthening…

1 year ago

Thirteen New Biospecimen Suppliers Added to iSpecimen’s Proprietary Provider Network

Network’s Expansion Across the U.S. and Europe Aims to Advance Translational Genomics ResearchLEXINGTON, Mass., July 06, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.

YUSIMRY™ (adalimumab-aqvh) product image YUSIMRY™ (adalimumab-aqvh) - list price $995 per carton of two 40 mg/0.8 mL autoinjectorsSee https://www.yusimry.com for…

1 year ago

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023 Annual General Meeting held on June 29, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 30, 2023 –…

1 year ago